<DOC>
	<DOC>NCT02214771</DOC>
	<brief_summary>The study aims to describe the characteristics and the methods of management and follow-up of patients treated with fidaxomicin for Clostridium difficile infection (CDI).</brief_summary>
	<brief_title>Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<criteria>Hospitalized patient Patient diagnosed with CDI Patient already included in this study Patient is taking part in a clinical trial in the field of CDI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Clostridium difficile infection CDI</keyword>
	<keyword>Observational</keyword>
	<keyword>Fidaxomicin recurrence</keyword>
	<keyword>France</keyword>
</DOC>